Ads
related to: otc- No Prescription Needed
Rx-Strength Allergy Eye Relief
From Common Allergens.
- Beat The Allergy Season
Pataday Offers Relief From Common
Eye Allergens. Learn More Today.
- No Prescription Needed
Search results
Gold demand including OTC was at eight-year high in Q1, WGC says
Reuters via Yahoo Finance· 42 minutes agoBy Polina Devitt LONDON (Reuters) - Global gold demand rose by 3% year-on-year to 1,238 metric tons...
Gold Demand Rose on Central-Bank, Over-The-Counter Buying
Morningstar· 38 minutes agoCentral-bank buying, over-the-counter purchases and higher demand from Asia kept gold in demand over the first quarter of the year, according to a report from the World Gold Council. Overall ...
Maximus Resources awarded co-funded EIS grant for Larkinville lithium drilling
Proactive Investors· 3 hours agoMaximus Resources Ltd (ASX:MXR, OTC:MXRRF) has welcomed a funding boost as it prepares for drilling...
Latin Resources delivers impressive quarter including another discovery and high-grade assays from...
Proactive Investors· 42 minutes agoDuring the March quarter Latin Resources Ltd (ASX:LRS, OTC:LRSRF) continued to progress activities at its 100%-owned Salinas Lithium Project in Minas Gerais, Brazil, including ...
Earnings call: AIA Group sees record VONB growth in Q1 2024 By Investing.com
Investing.com· 9 hours agoAIA Group (OTC:AAGIY) Limited (1299.HK) has reported a significant 31% increase in the value of new...
Why global gold demand marked its best first quarter in 8 years
Market Watch· 52 minutes agoTotal first-quarter gold demand, which includes the investment and industrial sectors and...
Earnings call: Hitachi forecasts robust growth and shareholder returns By Investing.com
Investing.com· 9 hours agoHitachi (OTC:HTHIY), Ltd. (6501.T) has reported a successful fiscal year with significant revenue...
Earnings call: Metso Outotec reports stable Q1 performance, aims for margin improvement By...
Investing.com· 10 hours agoMetso (OTC:MXTOF) Outotec (METSO.HE), a global leader in sustainable minerals and metals processing...
Earnings call: Repsol announces robust shareholder returns and strategic focus By Investing.com
Investing.com· 8 hours agoRepsol S.A. (OTC:REPYY), the Spanish energy company, has reported its first-quarter 2024 results,...
Orthocell achieves 85% success in Remplir™ nerve repair study; published in peer-reviewed journal
Proactive Investors· 4 hours agoOrthocell Ltd (ASX:OCC, OTC:ORHHF) has welcomed the publication of results from the clinical trial...